Digital Therapeutics

Latest News

The CDC suggests that disrupted access to ADHD medications may increase risk of overdose and injury.
CDC Issues HAN Health Advisory Following DOJ Indictment of Digital Health Provider of Adderall

June 14th 2024

The CDC suggests that disrupted access to ADHD medications may increase risk of overdose and injury.

An expert discusses the potential of smartphones as treatment measurement tools at the 2024 ASCP Annual Meeting.
Understanding the Effects of Pharmacotherapy Through Passive Data Collection

May 29th 2024

How does artificial intelligence have the potential to shape the future of psychiatry?
Making Sense of Chatbots

May 6th 2024

How can novel technologies help address stigma and improve care for patients with SUDs?
Improving Medical Education for SUDs With Technology

May 2nd 2024

Here are some updates from the world of psychiatry throughout the month of April.
Psychiatry in the News: April 2024

April 29th 2024

Video Interviews
Latest CME Events & Activities

Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis

View More

Advances In™ Schizophrenia: Expanding the Therapeutic Landscape

View More

Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia

View More

Southern California Psychiatry Conference

September 13-14, 2024

Register Now!

Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder

View More

2023 Annual Psychiatric Times™ World CME Conference

View More

5th Annual International Congress on the Future of Neurology®

View More

Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II

View More

Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments

View More

Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies

View More

'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care

View More

Real Psychiatry 2025

January 17 - 18, 2025

View More

More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression

View More

Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans

View More

Expert Perspectives in the Recognition and Management of Postpartum Depression

View More

More News

© 2024 MJH Life Sciences

All rights reserved.